简体中文

论著-头颈部

普美显磁共振增强成像在鉴别肝硬化结节与小肝癌的临床应用研究*

作者:郭天畅 伍彩云 温运雄 叶文卫 彭 森

所属单位:广东省东莞市第三人民医院放射科(广东 东莞 523109)

PDF

摘要

目的评估普美显(Gd-EOB-DTPA) MRI增强肝胆期对肝硬化结节与小肝癌的 鉴别与定性的价值。方法 20例肝硬化病 人行MRI平扫、普美显动态增强扫描及增 强扫描肝胆期扫描,对磁共振图像进行分 析,所有病例于磁共振检查后在4周内进 行穿刺活检或手术得出病理结果,影像诊 断与病理结果对照。结果 20例肝硬化病 人的86个结节中,常规平扫和动态增强扫 描检出小肝癌17例。增强扫描肝胆期检出 小肝癌21例。通过肝胆期扫描,对小肝癌 的敏感性及特异性、精确度均有提高,其 中3个恶变结节仅在肝胆期具有特征性。 结论 对肝硬化再生结节/增生结节与早期 肝细胞肝癌,肝胆期的敏感度及精确度高 于动态MRI增强扫描。普美显磁共振增强 扫描能早期检出有恶变倾向的肝硬化结节 和小肝癌。建议在肝硬化病人影像检查中 应广泛应用普美显的MRI增强检查。

Objective To assess the value of the identification and characterization of GdEOB-DTPA -MRI enhanced Hepatobiliary phase which have effect on cirrhosis nodules and small hepatocellular carcinoma. Methods Twenty patients of cirrhosis who had MRI scan, Gd-EOB-DTPA dynamic enhanced scan and Hepatobiliary stage enhanced scan. Magnetic resonance images were analyzed, all patients who had Magnetic resonance imaging (MRI) will have biopsy or surgical pathology results within 4 weeks. Besides, imaging diagnosis and surgical pathology results were control. Results 86 nodules were detected in twenty patients of cirrhosis, 17 cases of small hepatocellular carcinoma were detected through conventional unenhanced scan and enhanced scan while 21 cases of small hepatocellular carcinoma were detected. Through Hepatobiliary phase enhanced scan , the sensitivity and specificity of small hepatocellular carcinoma had improved, which has only three characteristics of malignant nodules in the liver and gallbladder period. Conclusion Contrast to cirrhosis nodular regenerative/hyperplastic nodules and early HCC, the sensitivity and accuracy of Hepatobiliary phase enhanced scan are higher than dynamic enhanced MRI scan. Gd-EOB-DTPA-enhanced MRI scan can early detect malignant nodules and cirrhosis of liver cancer. Gd-EOB-DTPA is recommended to apply to enhancement MRI examination in patients with cirrhosis.

【关键词】肝细胞癌;磁共振;肝硬化

【中图分类号】R657.3+1

【文献标识码】A

【DOI】10.3969/j.issn.1672-5131.2015.10.021

前言

近年来,肝细胞癌(Hepatocellular Carcinoma,HCC)的发病率在 全世界呈上升趋势,并以其高病死率严重地威胁着人类的健康。HCC的 早期诊断已成为医学界的前沿课题。而影像学以其无创性和直观性在 其中起着至关重要的作用。普美显(Gd-EOB-DTPA)为新型磁共振T1增 强造影剂,同时具有非特异性细胞外对比剂和肝胆特异性对比剂的特 性。对于HCC,特别是早期或者是小肝癌具有有其独特的优势。目前, 国内对普美显的应用大多仍处于研究阶段。本研究的目的是评估普美 显MRI增强肝胆期对肝硬化结节与小肝癌的鉴别与定性的价值。